| |
| |
|
| Insider
Information: |
Foletta Mark G |
| Relationship: |
EVP & Chief Financial ... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
110,512 |
|
|
Indirect Shares
|
59,092 |
|
|
| Direct
Value |
$1,213,952 |
|
|
|
Indirect Value
|
$7,347,499 |
|
|
| Total
Shares |
169,604 |
|
|
| Total
Value |
$8,561,451 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
1.0
|
| Percentage
Gain/Loss : |
 -0.0%
|
 13.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
SVP, Chief Financial O... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
DexCom Inc |
DXCM |
Director |
2023-05-18 |
3,306 |
2023-05-18 |
59,092 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2017-12-04 |
81,910 |
2015-08-13 |
0 |
Premium* |
|
|
AMN Healthcare Services Inc |
AHS |
Director |
2024-04-19 |
10,254 |
2016-04-20 |
0 |
Premium* |
|
|
Forte Biosciences Inc |
FBRX |
EVP & Chief Financial ... |
2019-05-28 |
15,042 |
2017-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2024-04-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,681 |
10,254 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2024-02-29 |
4 |
B |
$56.90 |
$28,450 |
D/D |
500 |
8,573 |
2.39 |
% |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2023-05-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,488 |
59,092 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2023-05-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,488 |
3,306 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$3 |
D/D |
3,306 |
7,794 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2023-04-21 |
4 |
AS |
$88.78 |
$129,441 |
D/D |
(1,458) |
8,073 |
0 |
% |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2023-04-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,458 |
9,531 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2023-04-11 |
4 |
AS |
$84.29 |
$509,638 |
D/D |
(6,042) |
8,073 |
0 |
% |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2022-11-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
300 |
14,115 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2022-05-20 |
4 |
A |
$0.00 |
$1 |
D/D |
1,122 |
1,122 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,054 |
13,651 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2022-05-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,054) |
0 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2022-04-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,139 |
14,415 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2021-11-01 |
4 |
AS |
$615.13 |
$313,162 |
I/I |
(500) |
13,097 |
0 |
% |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2021-10-01 |
4 |
AS |
$538.02 |
$271,547 |
I/I |
(500) |
13,597 |
0 |
% |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2021-06-11 |
4 |
S |
$95.02 |
$237,540 |
D/D |
(2,500) |
12,276 |
0 |
% |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
1,054 |
1,054 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
895 |
14,097 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2021-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(895) |
0 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2021-04-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,826 |
14,776 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2020-11-16 |
4 |
AS |
$336.98 |
$341,320 |
I/I |
(1,000) |
13,202 |
0 |
% |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2020-10-15 |
4 |
AS |
$391.48 |
$396,819 |
I/I |
(1,000) |
14,202 |
0 |
% |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2020-09-14 |
4 |
AS |
$386.21 |
$394,136 |
I/I |
(1,000) |
15,202 |
0 |
% |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2020-05-22 |
4 |
A |
$0.00 |
$1 |
D/D |
895 |
895 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2020-05-21 |
4 |
A |
$0.00 |
$0 |
I/I |
3,055 |
16,202 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
